NCT06397976

Brief Summary

This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2024

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2024

Completed
Last Updated

March 18, 2025

Status Verified

November 1, 2024

Enrollment Period

7 months

First QC Date

April 30, 2024

Last Update Submit

March 14, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Central Cornea Thickness

    Reproducibility and repeatability of Central Cornea Thickness of ANTERION and the reference device

    Through study completion, an average of 1 day

  • Thinnest Point Thickness

    Reproducibility and repeatability of Thinnest Point Thickness of ANTERION and the reference device

    Through study completion, an average of 1 day

  • Lens Thickness

    Reproducibility and repeatability of Lens Thickness of ANTERION and the reference device

    Through study completion, an average of 1 day

  • Anterior Chamber Depth

    Reproducibility and repeatability of Anterior Chamber Depth of ANTERION and the reference device

    Through study completion, an average of 1 day

  • Axial Length

    Reproducibility and repeatability of Axial Length of ANTERION and the reference device

    Through study completion, an average of 1 day

Secondary Outcomes (1)

  • Adverse Events Rate

    Through study completion, an average of 1 day

Study Arms (2)

Eyes with normal anterior segment

Device: ANTERION investigational

Eyes with abnormal anterior segment

Device: ANTERION investigational

Interventions

Measurements from the investigational device ANTERION with software version 1.5 are to be compared against measurements from the ANTERION with software version 1.2.4 (cleared version)

Eyes with abnormal anterior segmentEyes with normal anterior segment

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Eyes with normal and eyes with abnormal anterior segment population

You may qualify if:

  • Age 22 years or older
  • Able and willing to undergo the test procedures, sign informed consent, and follow instructions
  • Able to fixate
  • Eye(s) with normal anterior segment

You may not qualify if:

  • Active infection or inflammation in the study eye
  • Insufficient tear film or corneal reflex
  • Physical inability to be properly positioned at the study devices or eye exam equipment
  • Rigid contact lens wear 2 weeks prior to imaging
  • Soft lenses worn within one hour prior to imaging
  • Cataract grade ≥1.5
  • Age 22 years or older
  • Able and willing to undergo the test procedures, sign informed consent, and follow instructions
  • Able to fixate
  • Eye(s) with abnormal anterior segment (including cataract grade ≥ 1.5)
  • Active infection or inflammation in the study eye
  • Insufficient tear film or corneal reflex
  • Physical inability to be properly positioned at the study devices or eye exam equipment
  • Rigid contact lens wear 2 weeks prior to imaging
  • Soft lenses worn within one hour prior to imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fischer Eye Laser Center

Willmar, Minnesota, 56201, United States

Location

Study Officials

  • Jeffrey Fischer, MD

    Fischer Laser Eye Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 3, 2024

Study Start

April 17, 2024

Primary Completion

November 5, 2024

Study Completion

November 5, 2024

Last Updated

March 18, 2025

Record last verified: 2024-11

Locations